173 related articles for article (PubMed ID: 33247433)
1. Characterization of Isavuconazole serum concentrations after enteral feeding tube administration in a hospitalized cohort: A case series.
Spivey J; Wrenn R; Liu B; Maziarz E; Kram B
J Clin Pharm Ther; 2021 Apr; 46(2):528-531. PubMed ID: 33247433
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic drug concentrations of isavuconazole following the administration of isavuconazonium sulfate capsules via gastro-jejunum tube: A case report.
Adamsick ML; Elshaboury RH; Gift T; Mansour MK; Kotton CN; Gandhi RG
Transpl Infect Dis; 2019 Apr; 21(2):e13048. PubMed ID: 30636363
[TBL] [Abstract][Full Text] [Related]
3. Serial monitoring of isavuconazole blood levels during prolonged antifungal therapy.
Furfaro E; Signori A; Di Grazia C; Dominietto A; Raiola AM; Aquino S; Ghiggi C; Ghiso A; Ungaro R; Angelucci E; Viscoli C; Mikulska M
J Antimicrob Chemother; 2019 Aug; 74(8):2341-2346. PubMed ID: 31119272
[TBL] [Abstract][Full Text] [Related]
4. Clinical Pharmacokinetics and Pharmacodynamics of Isavuconazole.
McCarthy MW; Moriyama B; Petraitiene R; Walsh TJ; Petraitis V
Clin Pharmacokinet; 2018 Dec; 57(12):1483-1491. PubMed ID: 29725999
[TBL] [Abstract][Full Text] [Related]
5. A Case Series and Literature Review of Isavuconazole Use in Pediatric Patients with Hemato-oncologic Diseases and Hematopoietic Stem Cell Transplantation.
Decembrino N; Perruccio K; Zecca M; Colombini A; Calore E; Muggeo P; Soncini E; Comelli A; Molinaro M; Goffredo BM; De Gregori S; Giardini I; Scudeller L; Cesaro S
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31871077
[TBL] [Abstract][Full Text] [Related]
6. Treatment Failure of Isavuconazole in a Patient with Cryptococcosis.
Linder KA; Gandhi TN; Miceli MH
Mycopathologia; 2019 Oct; 184(5):667-670. PubMed ID: 31451965
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of oral isavuconazole in a patient after Roux-en-Y gastric bypass surgery.
Knoll BM
J Antimicrob Chemother; 2014 Dec; 69(12):3441-3. PubMed ID: 25114167
[No Abstract] [Full Text] [Related]
8. Real-life use of isavuconazole outside the hematological wards.
Scabini S; Lupia T; Angilletta R; De Rosa FG; Corcione S
Eur J Intern Med; 2019 Dec; 70():e10-e12. PubMed ID: 31526649
[No Abstract] [Full Text] [Related]
9. Pharmacodynamics of Isavuconazole for Invasive Mold Disease: Role of Galactomannan for Real-Time Monitoring of Therapeutic Response.
Kovanda LL; Kolamunnage-Dona R; Neely M; Maertens J; Lee M; Hope WW
Clin Infect Dis; 2017 Jun; 64(11):1557-1563. PubMed ID: 28472247
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of Intravenous Isavuconazole in Solid-Organ Transplant Recipients.
Wu X; Clancy CJ; Rivosecchi RM; Zhao W; Shields RK; Marini RV; Venkataramanan R; Nguyen MH
Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30275091
[TBL] [Abstract][Full Text] [Related]
11. High isavuconazole plasma levels in a patient with possible invasive pulmonary aspergillosis and cirrhosis.
Arsiè E; Piconi S; Iavarone M; Cozzi V; Lampertico P; Cattaneo D
Eur J Clin Pharmacol; 2018 Aug; 74(8):1089-1090. PubMed ID: 29666903
[No Abstract] [Full Text] [Related]
12. Isavuconazole for the treatment of invasive fungal disease in patients receiving ibrutinib.
Cummins KC; Cheng MP; Kubiak DW; Davids MS; Marty FM; Issa NC
Leuk Lymphoma; 2019 Feb; 60(2):527-530. PubMed ID: 30037292
[No Abstract] [Full Text] [Related]
13. Effect of mild and moderate liver disease on the pharmacokinetics of isavuconazole after intravenous and oral administration of a single dose of the prodrug BAL8557.
Schmitt-Hoffmann A; Roos B; Spickermann J; Heep M; Peterfaí E; Edwards DJ; Stoeckel K
Antimicrob Agents Chemother; 2009 Nov; 53(11):4885-90. PubMed ID: 19667286
[TBL] [Abstract][Full Text] [Related]
14. Isavuconazole for treatment of rare invasive fungal diseases.
Cornely OA; Mullane KM; Ostrosky-Zeichner L; Maher RM; Croos-Dabrera R; Lu Q; Lademacher C; Perfect JR; Oren I; Schmitt-Hoffmann AH; Giladi M; Marty FM; Rahav G
Mycoses; 2018 Aug; 61(8):518-533. PubMed ID: 29611246
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the pharmacokinetics and clinical utility of isavuconazole for treatment of invasive fungal infections.
Livermore J; Hope W
Expert Opin Drug Metab Toxicol; 2012 Jun; 8(6):759-65. PubMed ID: 22530880
[TBL] [Abstract][Full Text] [Related]
16. Achievement of clinical isavuconazole blood concentrations in transplant recipients with isavuconazonium sulphate capsules administered via enteral feeding tube.
McCreary EK; Nguyen MH; Davis MR; Borlagdan J; Shields RK; Anderson AD; Rivosecchi RM; Marini RV; Sacha LM; Silveira FP; Andes DR; Lepak AJ
J Antimicrob Chemother; 2020 Oct; 75(10):3023-3028. PubMed ID: 32710097
[TBL] [Abstract][Full Text] [Related]
17. Isavuconazole for treatment of invasive fungal diseases caused by more than one fungal species.
Marty FM; Cornely OA; Mullane KM; Ostrosky-Zeichner L; Maher RM; Croos-Dabrera R; Lu Q; Lademacher C; Oren I; Schmitt-Hoffmann AH; Giladi M; Rahav G; Perfect JR
Mycoses; 2018 Jul; 61(7):485-497. PubMed ID: 29611227
[TBL] [Abstract][Full Text] [Related]
18. Isavuconazole shortens the QTc interval.
Mellinghoff SC; Bassetti M; Dörfel D; Hagel S; Lehners N; Plis A; Schalk E; Vena A; Cornely OA
Mycoses; 2018 Apr; 61(4):256-260. PubMed ID: 29178247
[TBL] [Abstract][Full Text] [Related]
19. Enteral feeding tube administration with therapeutic drug monitoring of crushed posaconazole tablets and opened isavuconazonium sulfate capsules.
Dieringer TD; Schaenman JM; Davis MR
J Antimicrob Chemother; 2022 Apr; 77(5):1417-1423. PubMed ID: 35174391
[TBL] [Abstract][Full Text] [Related]
20. Impact of Mucositis on Absorption and Systemic Drug Exposure of Isavuconazole.
Kovanda LL; Marty FM; Maertens J; Desai AV; Lademacher C; Engelhardt M; Lu Q; Hope WW
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28289034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
